Sign inSubscribe

target directory

acute st elevation myocardial infarction clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.

Validated reports

1

Directory type

target

Association rule

normalized field

NCT04803864
Source recordAI-normalized

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Roxadustat in Patients With Acute ST Elevation Myocardial Infarction

This clinical trial evaluates the safety and efficacy of Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, in patients with acute ST elevation myocardial infarction. The study is conducted by Ruijin Hospital and aims to address the poor prognosis associated with this condition despite standard treatments.

AI analysis

Indication: ST Elevation Myocardial Infarction

Modality: small molecule

Target: Acute ST Elevation Myocardial Infarction

Sponsor: Ruijin Hospital

Source URL: ClinicalTrials.gov

Source updated: Sep 01, 2021

Ingested: May 30, 2026

Model: trialsignal-ai-v1

Validation: validated

Matched by target_normalized: Acute ST Elevation Myocardial Infarction

View original source fields

Condition raw: ST Elevation Myocardial Infarction

Condition normalized: ST Elevation Myocardial Infarction

Modality raw: ST Elevation Myocardial Infarction

Modality normalized: small molecule

Target raw: Acute ST Elevation Myocardial Infarction

Target normalized: Acute ST Elevation Myocardial Infarction

Open report